Matches in Wikidata for { <http://www.wikidata.org/entity/Q90284827> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q90284827 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90284827 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90284827 description "scientific article published on 01 September 2019" @default.
- Q90284827 description "wetenschappelijk artikel" @default.
- Q90284827 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q90284827 name "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 name "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 type Item @default.
- Q90284827 label "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 label "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 prefLabel "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 prefLabel "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patient" @default.
- Q90284827 P1433 Q90284827-511BAF7D-D1A1-4B22-92E8-4F43544BDB75 @default.
- Q90284827 P1476 Q90284827-D5E861DF-49FB-4299-B226-1055F7DD8CA1 @default.
- Q90284827 P2093 Q90284827-82277ABD-39FB-46C6-8B1E-E827089660C3 @default.
- Q90284827 P2093 Q90284827-870E4E50-CDAB-4DA5-A488-2D0559124A8A @default.
- Q90284827 P2093 Q90284827-A490C985-CBA0-4773-9F11-A3CA9336D466 @default.
- Q90284827 P2093 Q90284827-C2222DA2-191E-4C4D-B9A9-EAC258B0CD6A @default.
- Q90284827 P2860 Q90284827-1D7AB0FD-4566-4E98-8F83-84285DB74C7F @default.
- Q90284827 P2860 Q90284827-2519462F-86EE-40CF-AF8C-39558410B48C @default.
- Q90284827 P2860 Q90284827-3666B30E-DA64-4671-915C-7568881DA5D7 @default.
- Q90284827 P2860 Q90284827-5DE537BF-F31D-431D-A4EC-6DE2B310A835 @default.
- Q90284827 P2860 Q90284827-61FDD7AC-E213-4F9C-A793-93E4A4531A27 @default.
- Q90284827 P2860 Q90284827-6DC94A5C-D3F7-4CF8-989B-C4E20037908F @default.
- Q90284827 P2860 Q90284827-764B8871-C2CE-44CE-8291-27EFFD60CC8A @default.
- Q90284827 P2860 Q90284827-790A2332-AC71-4D93-88EB-1544F6D65D03 @default.
- Q90284827 P2860 Q90284827-88309F5A-7CFF-4759-B877-46506CC09C9A @default.
- Q90284827 P2860 Q90284827-B47CDB60-A429-4199-9D82-B39E51CF75EF @default.
- Q90284827 P2860 Q90284827-D8D8A945-5BAB-4C3C-B1DE-23F10C264B72 @default.
- Q90284827 P2860 Q90284827-DB9C998C-B327-43E5-B366-F0909C6ED8DC @default.
- Q90284827 P2860 Q90284827-FA1A78F6-9FB1-4F88-8463-7FC0EB8F34EF @default.
- Q90284827 P304 Q90284827-366D3AE3-4570-478E-9288-EAD20BAACE22 @default.
- Q90284827 P31 Q90284827-2E886284-9E54-4358-857A-D961EE10C028 @default.
- Q90284827 P356 Q90284827-892106AE-3C94-4341-869A-DFB66D863C8B @default.
- Q90284827 P433 Q90284827-A61D8181-486B-45C9-9A07-44F6C0ADFE4B @default.
- Q90284827 P478 Q90284827-48B33398-6295-485C-91F2-5D5BFA4776F7 @default.
- Q90284827 P50 Q90284827-342F4D9A-7BE9-4A77-8806-E2CED81DB809 @default.
- Q90284827 P50 Q90284827-8371A26F-8737-4F3B-9ADD-A205F95854E0 @default.
- Q90284827 P577 Q90284827-1AFF8746-9092-45CC-A74B-E30B12FF1367 @default.
- Q90284827 P698 Q90284827-F594310F-B3E4-4434-8E9A-91BB02F4E6F0 @default.
- Q90284827 P921 Q90284827-03492F2F-644B-41E8-9C62-2ACAC4D303C8 @default.
- Q90284827 P921 Q90284827-588992C2-8437-4BF6-A493-53247FABAD2A @default.
- Q90284827 P921 Q90284827-8587FFC3-3522-4077-B813-72321F2E3D5E @default.
- Q90284827 P932 Q90284827-6FC4AEAE-F43A-4EC3-B7E8-BB7A46EF87EE @default.
- Q90284827 P356 APJCP.2019.20.9.2733 @default.
- Q90284827 P698 31554370 @default.
- Q90284827 P1433 Q15759519 @default.
- Q90284827 P1476 "A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients" @default.
- Q90284827 P2093 "Kanda Fanhchaksai" @default.
- Q90284827 P2093 "Ruchirek Kamonrattana" @default.
- Q90284827 P2093 "Rungrote Natesirinilkul" @default.
- Q90284827 P2093 "Worawut Choeyprasert" @default.
- Q90284827 P2860 Q33975071 @default.
- Q90284827 P2860 Q34160380 @default.
- Q90284827 P2860 Q37344556 @default.
- Q90284827 P2860 Q40329901 @default.
- Q90284827 P2860 Q40388224 @default.
- Q90284827 P2860 Q40419049 @default.
- Q90284827 P2860 Q40484723 @default.
- Q90284827 P2860 Q40561453 @default.
- Q90284827 P2860 Q40644351 @default.
- Q90284827 P2860 Q40647627 @default.
- Q90284827 P2860 Q40700791 @default.
- Q90284827 P2860 Q46842147 @default.
- Q90284827 P2860 Q77054783 @default.
- Q90284827 P304 "2733-2737" @default.
- Q90284827 P31 Q13442814 @default.
- Q90284827 P356 "10.31557/APJCP.2019.20.9.2733" @default.
- Q90284827 P433 "9" @default.
- Q90284827 P478 "20" @default.
- Q90284827 P50 Q50997911 @default.
- Q90284827 P50 Q90284823 @default.
- Q90284827 P577 "2019-09-01T00:00:00Z" @default.
- Q90284827 P698 "31554370" @default.
- Q90284827 P921 Q408529 @default.
- Q90284827 P921 Q7197337 @default.
- Q90284827 P921 Q808845 @default.
- Q90284827 P932 "6976821" @default.